Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2024BMJOpen Access

4CPS-085 Long-term persistence in psoriasis patients with high response to guselkumab: a real-world retrospective study

View Full Paper
Ask AI
Bookmark
Share

Authors

ARA Valcuende RosiqueHospital de La RiberaJBJoaquín Borrás‐BlascoHospital de SaguntoSCSilvia CornejoHospital de Sagunto

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Rosique et al. (2024) studied this question.

synapsesocial.com/papers/68e7692cb6db6435876df266https://doi.org/10.1136/ejhpharm-2024-eahp.189
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 15PSQ-116 Real-world persistence with guselkumab among adults with psoriatic arthritis2024
  2. 24CPS-176 Use and persistence of guselkumab in treatment for rheumatic and dermatological disease2024 · 1 citations
  3. 3Long-Term Real-World Effectiveness and Drug Survival of Guselkumab in Patients with Psoriasis: A 5-Year Retrospective Study2025 · 8 citations
  4. 4Real-Life Effectiveness and Safety of Guselkumab in Patients with Psoriasis Who Have an Inadequate Response to Ustekinumab: A 3-Year Multicenter Study2024 · 6 citations
  5. 5Comparison of Real-World On-Label Treatment Persistence in Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Tumor Necrosis Factor Inhibitors2024 · 3 citations